0001104659-20-069071.txt : 20200602
0001104659-20-069071.hdr.sgml : 20200602
20200602185250
ACCESSION NUMBER: 0001104659-20-069071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200601
FILED AS OF DATE: 20200602
DATE AS OF CHANGE: 20200602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harrison Seth Loring
CENTRAL INDEX KEY: 0001404955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 20938517
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE, SUITE 2800
CITY: NEW YORK
STATE: NY
ZIP: 10169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
a4.xml
4
X0306
4
2020-06-01
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001404955
Harrison Seth Loring
C/O AKERO THERAPEUTICS, INC., 170
HARBOR WAY, 3RD FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
0
1
0
Stock Option (Right to Buy)
25.20
2020-06-01
4
A
0
13000
0
A
2030-05-31
Common Stock
13000
13000
D
This option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.
Under the Reporting Person's arrangement with Apple Tree Venture Management, LLC (the "Management Company"), the Reporting Person holds the option for the benefit of Apple Tree Partners IV, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Management Company any net cash received upon exercise of the option and sale of the underlying common stock, which will offset management fees owed by the Fund to the Management Company. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
/s/ Jonathan Young, attorney-in-fact
2020-06-02